U.S. immunotherapy company Inovio Pharmaceuticals Inc on Wednesday said its experimental vaccine to prevent coronavirus infection was shown to produce protective antibodies and immune system responses in mice and guinea pigs.
) on Wednesday said its experimental vaccine to prevent coronavirus infection was shown to produce protective antibodies and immune system responses in mice and guinea pigs.
“We saw antibody responses that do many of the things we would want to see in an eventual vaccine,” said Dr. David Weiner, director of the vaccine and immunotherapy center at the Wistar Institute, which has collaborated with Inovio. “We are able to target things that would prevent the virus from having a safe harbor in the body.”
“We are already seeing safety data and it has been benign,” Dr. Katherine Broderick, head of research and development at Inovio, told Reuters. “Some people have slight redness of the arm.” Inovio said the latest animal study results, published in the journal Nature Communications, validate its DNA medicines platform and build on previous positive clinical trial data for its experimental vaccine against a different, but related, coronavirus that causes Middle East Respiratory Syndrome.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
This Indian Paint Manufacturer Is Boosting Salaries Amid COVID-19 CrisisMumbai-headquartered Asian Paints surprised its 6,500-plus employees by announcing a salary raise to boost morale.
Lire la suite »
Children with COVID-19 may be less contagious than adults, two UK epidemiologists sayThere are tentative signs that children may not spread the novel coronavirus as much as adults, two top epidemiologists said on Tuesday, though they cautioned that the bad news was that human immunity may not last that long.
Lire la suite »
The Race to Develop a COVID-19 Vaccine, ExplainedWe talked to experts to better understand why it’s taking so long. The answer is complicated
Lire la suite »
Op-Ed: How the COVID-19 pandemic has created dire legal problems for the poorThat's why Congress' new coronavirus relief measure needs to increase funding for free legal services by $1 billion.
Lire la suite »
Florida Dad Recovers From COVID-19 One Month After Heart and Kidney Transplants: 'I'm a Survivor'Enell 'Trent' Porter had a dual transplant on the last day of February — weeks later, he, his wife and 5-year-old son battled the novel coronavirus
Lire la suite »
The forgotten front line: Nursing home workers say they face retaliation for reporting COVID-19 risks“When you hold them accountable, they see you as a nuisance,” a certified nursing aide at a Chicago nursing home said. “They’d rather have someone with less experience as long as you do what they say.”
Lire la suite »